Format

Send to

Choose Destination
Int J Cardiol. 2016 Jan 15;203:459-62. doi: 10.1016/j.ijcard.2015.10.199. Epub 2015 Oct 29.

Native T1 in deciphering the reversible myocardial inflammation in cardiac sarcoidosis with anti-inflammatory treatment.

Author information

1
Guy's and St Thomas' NHS Trust, London, United Kingdom; Department of Cardiovascular Imaging, King's College London, 4th Floor, Lambeth Wing, St. Thomas' Hospital, London, United Kingdom.
2
Department of Cardiovascular Imaging, King's College London, 4th Floor, Lambeth Wing, St. Thomas' Hospital, London, United Kingdom; Cardiovascular Magnetic Resonance Department, Fondazione CNR, Regione Toscana 'G. Monasterio', Pisa, Italy.
3
Department of Cardiovascular Imaging, King's College London, 4th Floor, Lambeth Wing, St. Thomas' Hospital, London, United Kingdom.
4
Guy's and St Thomas' NHS Trust, London, United Kingdom.
5
Guy's and St Thomas' NHS Trust, London, United Kingdom; Division of Cardiovascular Imaging, University Hospital Frankfurt, DZHK Centre for Cardiovascular Imaging, Frankfurt am Main, Germany.
6
Guy's and St Thomas' NHS Trust, London, United Kingdom; Goethe University Hospital Frankfurt, Department of Cardiology, Frankfurt am Main, Germany. Electronic address: vppapers@icloud.com.

KEYWORDS:

Cardiac sarcoidosis; Corticosteroid; Native T1

PMID:
26547739
DOI:
10.1016/j.ijcard.2015.10.199
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center